MELISSA MATTISON: Open Payments
NPI 1841613874 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 20 payments from 12 companies in 2025. Trend: 2023 $1,858 · 2024 $2,168 · 2025 $618
Food & beverage: $618
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $147 |
| HEARTFLOW, INC. | 1 | $129 |
| Actelion Pharmaceuticals US, Inc. | 3 | $83 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Abbott Laboratories | 2 | $44 |
| ABIOMED | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| BridgeBio Pharma, Inc. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: FFRct, VYNDAQEL, LifeVest, ELIQUIS, OPSUMIT, GALLANT, ENTRESTO, OPSYNVI.
Industry payments across AZ — which companies pay providers there.
